| ||||||||||||||
|
|
|||||||||||||
Received from the Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia; Hepatitis Branch, Viral Diseases Division, Centers for Disease Control, Atlanta, Georgia; University of California at San Francisco, San Francisco, California; University Hospitals of Cleveland, Cleveland, Ohio; University of California at Los Angeles, Los Angeles, California; Pennsylvania State University School of Medicine, Hershey, Pennsylvania; Max Kade Foundation and Stanford University School of Medicine, Palo Alto, California; and Northwestern University, Chicago, Illinois.
Abstract
Practicing anesthesiologists are at high risk of hepatitis B infection, but the risk for anesthesia residents has not been assessed. Anesthesia residents at seven universities were surveyed to study the epidemiology of hepatitis B in these trainees. Hepatitis B virus markers in serum were measured and data from questionnaires were used to determine characteristics of anesthetic practice, effectiveness of strategies for hepatitis B virus infection control, and nonvocational hepatitis B risk factors. Of 267 participants, 12.7% (range of the seven centers, 8.7%–22.7%) had serum markers for hepatitis B virus. The seropositivity (17.8%) in anesthesia residents who had completed more than 12 months of non-anesthesia postgraduate clinical training, or who had practiced medicine in another specialty prior to anesthesia, was greater than in the other trainees (9.4%). Based on their risk and the ineffectiveness of current control measures, anesthesia residents who lack hepatitis B virus immunity should be vaccinated prior to or as early as possible in their training.
Key Words: LIVER—hepatitis
|